Oncolytics Biotech Inc T.ONC

Pfizer & Thermo Fischer enter NGS testing agreement

[Noteable]

May 09, 2023 -  Pfizer and TMO announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients.

https://www.biospace.com/article/releases/thermo-fisher-scientific-and-amp-pfizer-partner-to-expand-localized-access-to-next-generation-sequencing-based-testing-for-cancer-patients-in-international-markets-/

[Noteable]

Under the agreement, Thermo Fisher will identify local labs that will be using the company's NGS technology and ensure they have the necessary infrastructure, trained staff, and quality control measures to meet industry standards for NGS testing services for breast and lung cancer.  [ So it would appear that Pfizer has moved towards the implementation of biomarker testing that ONCY's

[Noteable]

Should read: Thermo Fisher.